Chris Lorenz

Chris Lorenz is Senior Vice President of Technical Operations for Astellas Gene Therapies, and is responsible for the process development, manufacturing, supply chain, engineering, and facilities functions of our Gene Therapy operations. Chris joined Astellas Gene Therapies (formerly Audentes Therapeutics) in February 2016 to start up our manufacturing and warehouse functions in South San Francisco, and has taken on increasing levels of responsibility during his tenure at the company.

Mr. Lorenz joined Astellas Gene Therapies from Grifols Diagnostics Solutions (formerly Novartis Diagnostics) where he held various positions in their Manufacturing and Process Engineering functions. Prior to Grifols, he was at Genentech in South San Francisco where he held positions in their Process Development and Manufacturing Science & Technology organizations.

Mr. Lorenz earned both a Bachelor of Science and a Master of Science in Chemical Engineering from Stanford University.